Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6483]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
A first-of-its-kind prospective study of a multi-cancer blood test to screen...
Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer ( Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA )
13 May 2020
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...
Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )
5 May 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )
1 May 2020
New oncogenic drivers in NSCLC
Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )
23 Apr 2020
The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
The potential of KRAS inhibitors for non-small-cell lung cancer ( Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany )
22 Apr 2020
Managing multiple myeloma during the COVID-19 outbreak
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
17 Apr 2020
Immune checkpoint based approaches in AML and MDS
Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA
Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )
8 Apr 2020
Treating TRK fusion cancer: Selecting between available agents
Prof Marc Peeters and Dr David Hong
Treating TRK fusion cancer: Selecting between available agents ( Prof Marc Peeters and Dr David Hong )
3 Apr 2020
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast...
Dr. Geraldo Alves - Hospital Santa Rosa, Brasil
Testing and treatment for CDH1 in hereditary diffuse gastric cancer and breast cancer ( Dr. Geraldo Alves - Hospital Santa Rosa, Brasil )
26 Mar 2020
Haematological malignancies: Latest advances from ASH 2019
Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay
Haematological malignancies: Latest advances from ASH 2019 ( Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay )
10 Mar 2020
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Prof Marc Peeters and Prof Jesus Garcia-Foncillas
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019 ( Prof Marc Peeters and Prof Jesus Garcia-Foncillas )
9 Mar 2020
Working up metastatic NSCLC
Dr Depak Dabkara - Tata Medical Center, Kolkata, India
Working up metastatic NSCLC ( Dr Depak Dabkara - Tata Medical Center, Kolkata, India )
6 Mar 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation